Cargando…

Safety and efficacy of a non-polymeric paclitaxel-eluting microporous stent in real-world percutaneous coronary intervention

At present, there is an increasing focus on stents that have a biodegradable polymer coating, rather than a permanent polymer coating. This is due to the fact that following the implantation of a drug-eluting stent (DES) with a permanent polymer coating, the continued existence of the coating may re...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, SHAO-PENG, HUANG, RONG-CHONG, ZHU, HAO, ZHANG, BO, ZHENG, ZHEN-GUO, YIN, DA, WANG, JUN-JIE, ZHOU, XU-CHEN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786829/ https://www.ncbi.nlm.nih.gov/pubmed/24137271 http://dx.doi.org/10.3892/etm.2013.1217

Ejemplares similares

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012)

Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis
por: Meng, Min, et al.
Publicado: (2016)

Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies
por: Zhang, Xinlin, et al.
Publicado: (2014)

Brief Depression Screening with the PHQ-2 Associated with Prognosis Following Percutaneous Coronary Intervention with Paclitaxel-Eluting Stenting
por: Pedersen, Susanne S., et al.
Publicado: (2009)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Identification of functional modules induced by bare-metal stents and paclitaxel-eluting stents in coronary heart disease
por: Tang, Zhaobin, et al.
Publicado: (2018)

A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients with Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study
por: Kim, Ung, et al.
Publicado: (2013)

Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up
por: Pellegrini, Denise Oliveira, et al.
Publicado: (2014)

Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice
por: Youn, Young Jin, et al.
Publicado: (2023)

One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2016)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
por: Cho, Yun-Kyeong, et al.
Publicado: (2009)

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock
por: Mao, Chun-Tai, et al.
Publicado: (2019)

Effect of a paclitaxel-eluting metallic stent on rabbit esophagus
por: Zhang, Yin, et al.
Publicado: (2016)

Safety and performance of the EverPro(TM )everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario
por: Trimukhe, Rahul, et al.
Publicado: (2020)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Development of a Bioactive Polymeric Drug Eluting Coronary Stent Coating Using Electrospraying
por: McKittrick, C. M., et al.
Publicado: (2019)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas, Vasileios F, et al.
Publicado: (2015)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
por: Kumar, Basant, et al.
Publicado: (2021)

Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract
por: Jang, Sung Ill, et al.
Publicado: (2019)

Coronary pseudoaneurysm 1 week after complex percutaneous coronary intervention with drug‐eluting stent
por: Namazi, Mohammad Hasan, et al.
Publicado: (2020)

Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea
por: Lee, Joo Myung, et al.
Publicado: (2013)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Efficacy and safety of a biodegradable polymer sirolimus-eluting stent in primary percutaneous coronary intervention: a randomized controlled trial
por: Li, Qiang, et al.
Publicado: (2013)

Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Song, Pil Sang, et al.
Publicado: (2018)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency()
por: Marples, Rory, et al.
Publicado: (2021)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
por: Paramasivam, Ganesh, et al.
Publicado: (2019)

Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
por: Park, Sun-Kyung, et al.
Publicado: (2017)

Newer-Generation Drug-Eluting Stents in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Otsuka, Kenichiro
Publicado: (2021)

Two Cases of Percutaneous Intervention for Coronary Artery Bypass Graft Anastomoses With Paclitaxel-Eluting Balloon Catheters
por: Uhm, Jae-Sun, et al.
Publicado: (2011)

Use of Paclitaxel Eluting Stents in Arteriovenous Fistulas: A Pilot Study
por: Dinh, Krystal, et al.
Publicado: (2019)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice
por: Youn, Young Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b1h8ah1eecfcrbo0ovrjmveq8q